Skila Leads Sr. Executive Panel Discussion at the Bridging the Business Development/Alliance Management Interface Conference to be held on November 7-8, 2007

Morris Plains, NJ, October 13, 2007 – Skila, A Sela2 Company, has been requested to lead a Senior Executive panel discussion at the Cambridge Healthtech Institute (CHI) Bridging the Business Development/Alliance Management Interface Conference next month. On Thursday, November 8th, Skila will lead the panel discussion entitled “Bridging the Business Development/Alliance Management GAP and Beyond: Governance and Performance.” Senior Pharmaceutical Alliance executives will discuss their perspectives and best-practices of how cross-functional teams should work together in managing the process of defining, shadowing, governing, viewing, assessing, managing and communicating the performance of opportunities and shared assets – even after becoming fully functional alliances.

The Bridging the Business Development/Alliance Management Interface conference recognizes the model for development of new Pharmaceutical products is changing rapidly and Pharma must respond. Alternative sourcing programs are emerging; alliances are becoming more and more central to new product development as alliance centric external development programs emerge; and movements towards better integration of business development and alliance management functions are key to the integration of alliances. In addition, acquisitions are transforming how companies are finding, evaluating, structuring and negotiating deals and working with their external partners. For Business Development and Alliance Management Teams to effectively work together, both must be equipped to quickly view, assess, manage and communicate key performance indicators and milestones that enable, through mutual governance and performance management, effective outcomes specific to opportunities and potential assets.

Susan Dorfman, VP of Worldwide Marketing, Skila, will act as the moderator and the impressive list of current panel experts include Mike Leonetti, Chairman, Board of Directors, ASAP, Executive Director, Healthcare Partnerships, Boehringer-Ingelheim Pharmaceuticals, Inc.; Kimberly Brue, Director, Alliance Management, Sanofi Pasteur; Ratnakar Mitra, Vice President, Alliance Management and Licensing, Schering Plough; Kathleen Holt, Ph.D., Senior Director Alliance and Project Management, Lexicon Pharmaceutical; Moish Tov, CEO, Skila.

For more information regarding Skila, go to www.skila.com. To register for the Business Development/Alliance Management Interface conference, go to www.pharmaseries.com.

About Skila
For over 12 years Skila has been recognized as a global leader in delivering global sales and marketing effectiveness solutions and platforms to pharmaceutical and biotechnology companies world-wide. Skila’s single touch-point solutions foster multi-way communication and the sharing of best practices, while incorporating built-in actions that augment world-wide collaboration and drive more coordinated management of global brand resources, assets and best practices.

With a unique blend of expert business advisory, proven business process methodologies, innovative pull through services, and our proprietary Intelligration® technology, Skila’s solutions have helped teams around the globe to identify, gather, present and distribute actionable knowledge - while compiling a fluid map of who knows what within the global organization. Skila’s solutions have been adopted by many of the leading companies in the industry, including: Boehringer Ingelheim, Roche, Eli Lilly & Company, Allergan and Gilead. To date, our solutions have helped facilitate:
• Over Ten Million user interactions
• In 56 countries
• Across 11 therapeutic categories
• For more then 30 brands

While other marketing effectiveness approaches offer clients either consultative services or technology that must be owned and managed solely by internal teams in order to remain operational, Skila’s full-service solutions use a proven blend of web-based technology, methodology and on-going support to ensure results.

Skila’s managed solutions:
• Help life science organizations realize strategic goals by operationalizing strategy into actionable, manageable and measurable tasks
• Empower teams to access, share, collaborate, enhance, optimize and maximize the efficacy and efficiency of their marketing efforts locally, regionally, and across the global enterprise
• Ensure on-going relevance, support and usage
• Enable the creation, adoption and dissemination of best practices
• Provide rapid access to timely, critical information
• Assess and manage performance, while adjusting tactics accordingly
• Are relied on and valued by Pharmaceutical companies and brands world-wide.
###